4D Nucleofector Transfection Instrument
Closed Solicitation Posted
- Solicitation number
- 75N95024Q00414
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to procure a brand name or equal 4D Nucleofector system and component parts for genome engineering of human induced pluripotent stem cells (hiPSCs) using CRISPR-Cas9 technology. NINDS requires a system that will provide precise and efficient gene editing tools, especially for applications in regenerative medicine and disease modeling. The solicitation will be conducted under FAR Part 12 and 13 procedures, with award based on technical capability, contract management, delivery, and past performance considerations. Responses are due by September 3, 2024.
This opportunity is not set aside for any particular business category. The government has not provided any details on potential incumbents or current contractors. The government has also not specified an award value or budget range. The required delivery for the 4D Nucleofector system and component parts is 30 days After Receipt of Order (ARO) to the Ward Lab in Bethesda, MD 20892.
Notice text
The National Institute of Neurological Disorders andStroke (NINDS) requires a brand name or equal 4D Nucleofector system andcomponent parts for genome engineering of human induced pluripotent stem cells(hiPSCs) using CRISPR-Cas9 technology. NINDS requires a system that will provideprecise and efficient gene editing tools, especially for applications in regenerativemedicine and disease modeling. NINDS requires a 4D Nucleofector that allows forprecise and efficient gene editing tools, especially for applications in regenerativemedicine and disease modeling. NINDS intends to utilize this system for the introductionof CRISPR Cas9 RNPs into iPSCs to introduce neurodegeneration related mutations.
Files
| File | Type | Posted |
|---|---|---|
| Att 1- Product Description.pdf | ||
| CSS No. 75N95024Q00414.pdf | ||
| ATT 3 - FAR 52.212-5.pdf | ||
| ATT 4 - IPP Instructions.pdf | ||
| ATT 2 - FAR 52.212-4.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Electroporation-based Transfection Instrument | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| iPSC Culture and Differentiation | Office of Logisitics and Acquisition Operations | No set-aside | |
| NCSS - Bioruptor Pico Sonication Device | Office of Logisitics and Acquisition Operations | No set-aside | |
| RNA sequencing and whole genome sequencing services | Office of Logisitics and Acquisition Operations | No set-aside | |
| DNA Sequencing Service | Office of Logisitics and Acquisition Operations | No set-aside | |
| NCSS - Onboarding NHLBI to NEI OpenSpecimen | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity